Millenium Myosight; dual-head nuclear medicine gamma camera designed specifically for cardiac imaging — FDA record Z-0298-2026

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Sep 12, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Millenium Myosight; dual-head nuclear medicine gamma camera designed specifically for cardiac imaging
Reason
GE HealthCare has become aware that certain Nuclear Medicine systems that are past the End of Guaranteed Service could have been transported or relocated without adequate detector support. This could result in excessive stress being applied to the detector mounting mechanisms, compromising their integrity. If this occurs, it can potentially result in a detector fall and lead to life-threatening bodily injury.
Classification
Class II
Recalling firm
GE MEDICAL SYSTEMS ISRAEL, FUNCTIONAL IMAGING
Quantity
82 units
Agency-reported status
Ongoing
Source record identifier
Z-0298-2026

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityall serial numbers in distribution

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Worldwide

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Report date
Oct 29, 2025
Recall initiation date
Sep 12, 2025
Center classification date
Oct 23, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records